Commodore Capital’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,350,000
Closed -$44.7M 34
2024
Q3
$44.7M Sell
3,350,000
-1,307,345
-28% -$17.5M 2.79% 14
2024
Q2
$46.4M Buy
4,657,345
+2,552,082
+121% +$25.4M 3.17% 14
2024
Q1
$25.1M Buy
+2,105,263
New +$25.1M 1.68% 22